🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I study to evaluate the safety and tolerability of sacituzu...
Status
Recruiting
Location
Henry Ford Cancer-Detroit
Start Date
2024-11-20
Trial ID
NCT06065371
Treatments Being Tested
In our study; investigator aim To show efficacy and toxicity of Adjuvant ci...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-30
Trial ID
NCT06268327
Treatments Being Tested
To evaluate the safety and efficacy of irinotecan and capecitabine in Asian...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-11
Trial ID
NCT00635323
Treatments Being Tested
A multicenter, randomized, open-label, three-period, and reference-replicat...
Status
Completed
Location
Phase Ⅰ Clinical Research Center
Start Date
2018-12-10
Trial ID
NCT04420871
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as capecitabine, work in differ...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-01
Trial ID
NCT00357253
Treatments Being Tested
This randomized, open-label, two-way crossover study will evaluate the rela...
Status
Completed
Location
Multiple Locations
Start Date
2012-05
Trial ID
NCT01493336
Treatments Being Tested
This is an open-label, non-comparative phase II study of sequential capecit...
Status
Terminated
Location
National Health Research Institutes
Start Date
2012-03
Trial ID
NCT01558011
Treatments Being Tested
Gastric cancer remains a significant global public health problem. Although...
Status
Active Not Recruiting
Location
Calvary Mater Newcastle
Start Date
2009-09
Trial ID
NCT01924819
The purpose of this clinical trial is to determine if RPR109881 is a better...
Status
Completed
Location
Multiple Locations
Start Date
2004-04
Trial ID
NCT00081796
Treatments Being Tested
Local study in China and Hong Kong to evaluate safety and efficacy in lapat...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2007-07-18
Trial ID
NCT00508274
Treatments Being Tested